pharmaceuticals

https://youtu.be/ZZNGEHlRimc Key highlights from Aurobindo Pharma Limited (AUROPHARMA) Q4 FY22 Earnings Concall Management Update: AUROPHARMA received final approval for 3…

https://youtu.be/3z2q_SR1OS4 Key highlights from Hikal Limited (HIKAL) Q4 FY22 Earnings Concall Management Update: HIKAL said its new product launches in…

https://youtu.be/uTUQ9VpSoiU Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q4 FY22 Earnings Concall Management Update: GLENMARK said the India business continues…

Aurobindo Pharma Ltd (NSE: AUROPHARMA) Q4 FY22 Earnings Concall dated May 30, 2022 Corporate Participants: Deepthi Thakur -- Investor Relations Santhanam Subramanian -- Chief…

Key highlights from Piramal Enterprises Ltd (PEL) Q4 FY22 Earnings Concall Management Update: Over the next five years, PEL aspire…

Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q4 FY22 Earnings Concall Q&A Highlights: Anubhav Aggarwal of Credit Suisse asked about…

https://youtu.be/VIL70Aj2g04 Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q4 FY22 Earnings Concall Management Update: SUPRIYA said that going forward the…

https://youtu.be/MLu1npKFqZg Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q4 FY22 Earnings Concall Management Update: DIVISLAB said it reached milestone revenue…

Dr. Reddy's Laboratories (NSE: DRREDDY) Q4 FY22 Earnings Concall dated May 19, 2022 Corporate Participants: Amit Agarwal -- Head of Investor Relations…

Gland Pharma Ltd. (NSE: GLAND) Q4 FY22 Earnings Concall dated May 19, 2022 Corporate Participants: Sumanta Bajpayee -- Vice President-Finance & Investor…